Investment Counsel Company of Nevada’s ResMed RMD Stock Holding History

Investment Counsel Company of Nevada’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-800	Closed	-$180K	–	185
2026 Q1	$180K	Hold	800	–	–	0.4%	24
2025 Q4	$193K	Hold	800	–	–	0.41%	23
2025 Q3	$219K	Hold	800	–	–	0.45%	26
2025 Q2	$206K	Hold	800	–	–	0.42%	34
2025 Q1	$179K	Hold	800	–	–	0.41%	33
2024 Q4	$183K	Buy	+800	New	+$193K	0.46%	19

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Investment Counsel Company of Nevada's RMD Position: Q2 2026 in Review

Investment Counsel Company of Nevada sold out of ResMed (RMD) in Q2 2026, closing a stake of 800 shares — an estimated $180K sold.

Investment Counsel Company of Nevada first reported a position in RMD in Q4 2024 and held it in 6 quarters. The position peaked at $219K in Q3 2025. 605 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Investment Counsel Company of Nevada reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Investment Counsel Company of Nevada sold 800 ResMed shares in Q2 2026, an estimated $180K.
Investment Counsel Company of Nevada first reported a position in ResMed in Q4 2024 and held it in 6 quarters.
Investment Counsel Company of Nevada's ResMed position peaked at $219K in Q3 2025.
605 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Investment Counsel Company of Nevada's 13F filing for Q2 2026, filed 10 Aug 2026.